Soothing liver-qi stagnation method for cancer-related depression: A protocol for systematic review and meta-analysis
- PMID: 33120798
- PMCID: PMC7581120
- DOI: 10.1097/MD.0000000000022797
Soothing liver-qi stagnation method for cancer-related depression: A protocol for systematic review and meta-analysis
Abstract
Background: Cancer-related depression (CRD) is the most common mood disorder in patients with malignant tumors, negatively influencing the patient's daily life. Traditional Chinese medicine, as an alternative CRD therapy, has shown good treatment performance in recently years. Soothing liver-qi stagnation, as a classic therapy for depression, is based on traditional Chinese medicine theory. However, there is no evidence-based medical confirmation for the soothing liver-qi stagnation method for CRD treatment.
Methods: We will systematically search relevant articles from their inception to July 1, 2019 in the following electronic databases: the Cochrane Library, PubMed, EMBASE, Chinese National Knowledge Infrastructure Database, Chinese Biomedical Literature Database, Chinese Science and Technique Journals Database, and the Wan-fang Database. The primary outcome is the total scores of the Hamilton rating scale for depression and, the efficacy rate of reducing Hamilton rating scale for depression scores. The secondary outcomes are adverse reactions and quality of life as assessed by standard instruments. Two researchers will independently perform study selection, data extraction, and quality assessment. If there is any disagreement, it will be settled through third-party negotiations. We will assess the risk of bias and data synthesis using Review Manager (the Cochrane Collaboration) software, Version 5.3.0.
Results: This work will evaluate the clinical effectiveness and safety of the soothing liver-qi stagnation method for CRD.
Conclusion: This study may provide evidence-based medical corroboration for clinical application of the soothing liver-qi stagnation method for CRD treatment.
Prospero registration number: CRD42019145678.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Similar articles
-
Research on the soothing Liver - Qi stagnation method in the treatment of postoperative papillary thyroid carcinoma patients' concomitant depression: A randomized controlled clinical trial.Medicine (Baltimore). 2024 Sep 13;103(37):e39325. doi: 10.1097/MD.0000000000039325. Medicine (Baltimore). 2024. PMID: 39287310 Free PMC article. Clinical Trial.
-
Efficacy and safety of oral traditional Chinese patent medicine in treatment of liver stagnation and spleen deficiency of depression: A protocol for systematic review.Medicine (Baltimore). 2020 Feb;99(7):e19142. doi: 10.1097/MD.0000000000019142. Medicine (Baltimore). 2020. PMID: 32049837 Free PMC article.
-
Efficacy and safety of Qi and Blood Tonic Chinese Medicines in the treatment of COVID-19: A protocol for systematic review and meta-analysis.Medicine (Baltimore). 2022 Dec 9;101(49):e32136. doi: 10.1097/MD.0000000000032136. Medicine (Baltimore). 2022. PMID: 36626419 Free PMC article.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
The clinical efficacy and safety of the Chinese herbal medicine Astragalus (Huangqi) preparation for the treatment of acute myocardial infarction: A systematic review of randomized controlled trials.Medicine (Baltimore). 2019 Apr;98(16):e15256. doi: 10.1097/MD.0000000000015256. Medicine (Baltimore). 2019. PMID: 31008964 Free PMC article.
Cited by
-
Soothing the liver and activating blood circulation for the treatment of chronic prostatitis: A systematic review and meta-analysis.Medicine (Baltimore). 2025 Jun 13;104(24):e42180. doi: 10.1097/MD.0000000000042180. Medicine (Baltimore). 2025. PMID: 40527809 Free PMC article.
-
Global research trends on gastrointestinal cancer and mental health (2004-2024): a bibliographic study.Front Med (Lausanne). 2025 Jan 28;12:1515853. doi: 10.3389/fmed.2025.1515853. eCollection 2025. Front Med (Lausanne). 2025. PMID: 39935799 Free PMC article.
-
An Ethanol Extract of Perilla frutescens Leaves Suppresses Adrenergic Agonist-Induced Metastatic Ability of Cancer Cells by Inhibiting Src-Mediated EMT.Molecules. 2023 Apr 12;28(8):3414. doi: 10.3390/molecules28083414. Molecules. 2023. PMID: 37110648 Free PMC article.
-
The Herbal Combination Shu Gan Jie Yu Regulates the SNCG/ER-a/AKT-ERK Pathway in DMBA-Induced Breast Cancer and Breast Cancer Cell Lines Based on RNA-Seq and IPA Analysis.Integr Cancer Ther. 2024 Jan-Dec;23:15347354241233258. doi: 10.1177/15347354241233258. Integr Cancer Ther. 2024. PMID: 38369762 Free PMC article.
-
Whole-process case management effects on mental state and self-care ability in patients with liver cancer.World J Gastrointest Surg. 2024 Mar 27;16(3):833-841. doi: 10.4240/wjgs.v16.i3.833. World J Gastrointest Surg. 2024. PMID: 38577082 Free PMC article.
References
-
- Mehnert A, Brähler E, Faller H, et al. Four-week prevalence of mental disorders in patients with cancer across major tumor entities. J Clin Oncol 2014;32:3540–6. - PubMed
-
- Bortolato B, Hyphantis TN, Valpione S, et al. Depression in cancer: the many biobehavioral pathways driving tumor progression. Cancer Treat Rev 2017;52:58–70. - PubMed
-
- Götze H, Friedrich M, Taubenheim S, et al. Depression and anxiety in long-term survivors 5 and 10 years after cancer diagnosis. Support Care Cancer 2020;28:211–20. - PubMed
-
- Ferrari M, Ripamonti CI, Hulbert-Williams NJ, et al. Relationships among unmet needs, depression, and anxiety in non-advanced cancer patients. Tumori 2019;105:144–50. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical